The stock has a 36-month beta value of 0.87. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for HOOK is 6.98M, and at present, short sellers hold a 0.43% of that float. On May 22, 2025, the average trading volume of HOOK was 86.76K shares.
HOOK) stock’s latest price update
Hookipa Pharma Inc (NASDAQ: HOOK)’s stock price has plunge by 12.50relation to previous closing price of 1.52. Nevertheless, the company has seen a 17.93% surge in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-20 that NEW YORK and VIENNA, Austria, Feb. 20, 2025 (GLOBE NEWSWIRE) — NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
HOOK’s Market Performance
Hookipa Pharma Inc (HOOK) has seen a 17.93% rise in stock performance for the week, with a 119.23% gain in the past month and a -3.93% plunge in the past quarter. The volatility ratio for the week is 12.39%, and the volatility levels for the past 30 days are at 14.70% for HOOK. The simple moving average for the past 20 days is 27.30% for HOOK’s stock, with a -35.26% simple moving average for the past 200 days.
Analysts’ Opinion of HOOK
Many brokerage firms have already submitted their reports for HOOK stocks, with RBC Capital Mkts repeating the rating for HOOK by listing it as a “Sector Perform.” The predicted price for HOOK in the upcoming period, according to RBC Capital Mkts is $2 based on the research report published on December 20, 2024 of the previous year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see HOOK reach a price target of $48, previously predicting the price at $50. The rating they have provided for HOOK stocks is “Outperform” according to the report published on November 15th, 2024.
BofA Securities gave a rating of “Underperform” to HOOK, setting the target price at $0.50 in the report published on December 02nd of the previous year.
HOOK Trading at 52.24% from the 50-Day Moving Average
After a stumble in the market that brought HOOK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.37% of loss for the given period.
Volatility was left at 14.70%, however, over the last 30 days, the volatility rate increased by 12.39%, as shares surge +97.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +32.80% upper at present.
During the last 5 trading sessions, HOOK rose by +14.48%, which changed the moving average for the period of 200-days by -64.45% in comparison to the 20-day moving average, which settled at $1.3408. In addition, Hookipa Pharma Inc saw -14.93% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HOOK
Current profitability levels for the company are sitting at:
- -10.95 for the present operating margin
- 0.9 for the gross margin
The net margin for Hookipa Pharma Inc stands at -9.98. The total capital return value is set at -1.8. Equity return is now at value -105.79, with -70.79 for asset returns.
Based on Hookipa Pharma Inc (HOOK), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -88.54.
Currently, EBITDA for the company is -40.85 million with net debt to EBITDA at 0.54. When we switch over and look at the enterprise to sales, we see a ratio of -2.58. The receivables turnover for the company is 13.48for trailing twelve months and the total asset turnover is 0.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.61.
Conclusion
To sum up, Hookipa Pharma Inc (HOOK) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
